Incidence and Mortality of Colorectal Cancer and Relationships with the Human Development Index across the World

  • Rafiemanesh, Hosein (Department of Epidemiology and Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences) ;
  • Mohammadian-Hafshejani, Abdollah (Department of Social Medicine, School of Medicine, Rafsanjan University of Medical Sciences) ;
  • Ghoncheh, Mahshid (Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences) ;
  • Sepehri, Zahra (Department of Internal Medicine, Zabol University of Medical Sciences) ;
  • Shamlou, Reza (Department of Elder Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences) ;
  • Salehiniya, Hamid (Department of Epidemiology and Biostatistics, School of Public Health, School of Nursing and Midwifery, Tehran University of Medical Sciences) ;
  • Towhidi, Farhad (D Imam Reza Hospital, Kermanshah University of Medical Sciences) ;
  • Makhsosi, Behnam Reza (D Imam Reza Hospital, Kermanshah University of Medical Sciences)
  • Published : 2016.05.01


Background: This study aimed to investigate the standardized incidence and mortality rate of colorectal cancer and its relationship with the human development index (HDI) across the world in 2012. Materials and Methods: This ecologic study was conducted for assessment of the correlation between age-specific incidence rate (ASIR) and age-specific mortality rate (ASMR) with HDI and its components. Data for SIR and SMR for every country for the year 2012 were obtained from the global cancer project. We used a bivariate method for assessment of the correlation between SIR and SMR and HDI. Statistical significance was assumed at P<0.05. Statistical analyses were performed using SPSS (Version 22.0, SPSS Inc.). Results: Countries with the highest SIR of colorectal cancer in the world in 2012, were Republic of Korea, Slovakia, Hungary and countries with the highest SMR were Hungary, Croatia and Slovakia. The correlation between SIR of colorectal cancer and the HDI was 0.712 ($P{\leq}0.001$), with life expectancy at birth 0.513 ($P{\leq}0.001$), with mean years of schooling 0.641 ($P{\leq}0.001$) and with level of income per each person of the population 0.514 (P=0.013). In addition, the correlation between SMR of colorectal cancer and the HDI was 0.628 ($P{\leq}0.001$), with life expectancy at birth 0.469 ($P{\leq}0.001$), with mean years of schooling 0.592 ($P{\leq}0.001$) and with level of income per each person of the population 0.378 (P=0.013). Conclusions: The highest SIR and SMR of colorectal cancer was in the WHO Europe region. There was a positive correlation between HDI and SIR and SMR of colorectal cancer.


Colorectal cancer;incidence;mortality;human development index;world


  1. Aguero F, Murta-Nascimento C, Gallen M, et al (2012). Colorectal cancer survival: results from a hospital-based cancer registry. Rev Esp Enferm Dig, 104, 572-7.
  2. Ahmadi A, Nazari SSH, Mobasheri M (2014). Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry. Med J Islamic Republic Iran, 28, 83.
  3. Alexander DD, Cushing CA (2011). Red meat and colorectal cancer: a critical summary of prospective epidemiologic studies. Obes Rev, 12, 472-93.
  4. Alikhani S, Delavari A, Alaedini F, et al (2009). A province-based surveillance system for the risk factors of non-communicable diseases: A prototype for integration of risk factor surveillance into primary healthcare systems of developing countries. Public Health, 123, 358-64.
  5. Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev, 16, 2757-61.
  6. Aune D, Lau R, Chan DS, et al (2011). Nonlinear reduction in risk for colorectal cancer by fruit and vegeTable intake based on meta-analysis of prospective studies. Gastroenterol, 141, 106-18.
  7. Baxter NN, Warren JL, Barrett MJ, et al (2012). Association between colonoscopy and colorectal cancer mortality in a us cohort according to site of cancer and colonoscopist specialty. J Clin Oncol, 30, 2664-9.
  8. Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801.
  9. Chan AT, Giovannucci EL (2010). Primary prevention of colorectal cancer. Gastroenterol, 138, 2029-43.
  10. Coleman MP, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38.
  11. Coleman MP, Quaresma M, Berrino F, et al (2008). Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol, 9, 730-56.
  12. Corrao MA, Guindon GE, Cokkinides V, et al (2000). Building the evidence base for global tobacco control. Bull WHO, 78, 884-90.
  13. Donohoe CL, Pidgeon GP, Lysaght J, et al (2010). Obesity and gastrointestinal cancer. Br J Surg, 97, 628-42.
  14. Downing A, Aravani A, Macleod U, et al (2013). Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis. Br J Cancer, 108, 681-5.
  15. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, E359-86.
  16. Ferrari F, Reis MA (2013). Study of risk factors for gastric cancer by populational databases analysis. World J Gastroenterol, 19, 9383-91.
  17. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015). Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev, 16, 6081-7.
  18. Giebel S, Labopin M, Ehninger G, et al (2010). Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. Blood, 116, 122-8.
  19. Hajmanoochehri F, Asefzadeh S, Kazemifar AM, et al (2014). Clinicopathological features of colon adenocarcinoma in Qazvin, Iran: a 16 year study. Asian Pac J Cancer Prev, 15, 951-5.
  20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  21. Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
  22. Jung KW, Won YJ, Kong HJ, et al (2013). Survival of Korean adult cancer patients by stage at diagnosis, 2006-2010: National Cancer Registry Study. Cancer Res Treatment, 45, 162-71.
  23. Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50.
  24. Key TJ (2011). Fruit and vegetables and cancer risk. Br J Cancer, 104, 6-11.
  25. Larsen IK, Smastuen M, Johannesen TB, et al (2009). Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. European J Cancer, 45, 1218-31.
  26. Liu Y, Arai A, Obayashi Y, et al (2013). Trends of gender gaps in life expectancy in Japan, 1947-2010: associations with gender mortality ratio and a social development index. Geriatr Gerontol Int, 13, 792-7.
  27. Malik K (2013). Human development report 2013. The rise of the south: Human progress in a diverse world. The Rise of the South: Human Progress in a Diverse World (March 15, 2013). UNDP-HDRO Human Development Reports.
  28. Mallin K, Palis BE, Watroba N, et al (2013). Completeness of American cancer registry treatment data: implications for quality of care research. J Am Coll Surg, 216, 428-37.
  29. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015). The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int, 3, 135-40.
  30. Pakzad R, Mohammadian-Hafshejani A, Mohammadian M, et al (2014). Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia. Asian Pacific journal of cancer prevention: APJCP, 16, 7365-74.
  31. Perdue DG, Haverkamp D, Perkins C, et al (2014). Geographic Variation in Colorectal Cancer Incidence and Mortality, Age of Onset, and Stage at Diagnosis Among American Indian and Alaska Native People, 1990-2009. American Journal of Public Health, 104, 404-14.
  32. Programme UND. 2015. Human Development Report. (Online). [Online].
  33. Razi S, Rafiemanesh H, Ghoncheh M, et al (2015). Changing Trends of Types of Skin Cancer in Iran. Asian Pac J Cancer Prev, 16, 4955-8.
  34. Singh S, Singh PP, Murad MH, et al (2014). Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol, 109, 1375-89.
  35. Sunkara V, Hebert JR (2015). The Colorectal Cancer Mortalityto-Incidence Ratio as an Indicator of Global Cancer Screening and Care. Cancer, 121, 1563-9.
  36. Torring ML, Frydenberg M, Hansen RP, et al (2011). Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer, 104, 934-40.
  37. Zauber AG (2015). The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Digestive Diseases Sci, 60, 681-91.
  38. Zauber AG, Winawer SJ, O'Brien MJ, et al (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med, 366, 687-96.